Tipepidine Hibenzate

羟苯酰苯酸替培啶

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameTipepidine Hibenzate

Drug Alias Name海苯酸替培啶TipidineCofedeninAsverinCousel +[12]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityAttention Deficit and Disruptive Behavior DisordersDepression +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesChiba University

Active IndicationsCough

Inactive IndicationsAttention Deficit Disorder with HyperactivityAttention Deficit and Disruptive Behavior DisordersDepression +[4]

ATC CodeR05DB24